Valentine Capital Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $257K | Sell |
1,350
-225
| -14% | -$42.8K | 0.29% | 66 |
|
|
2015
Q3 | $246K | Sell |
1,575
-540
| -26% | -$84.3K | 0.22% | 76 |
|
|
2015
Q2 | $382K | Sell |
2,115
-1,970
| -48% | -$356K | 0.26% | 69 |
|
|
2015
Q1 | $708K | Sell |
4,085
-1,340
| -25% | -$232K | 0.21% | 83 |
|
|
2014
Q4 | $1M | Buy |
5,425
+90
| +2% | +$16.7K | 0.24% | 83 |
|
|
2014
Q3 | $885K | Buy |
+5,335
| New | +$885K | 0.34% | 42 |
|
|
2014
Q2 | – | Sell |
-54,978
| Closed | -$8.36M | – | 131 |
|
|
2014
Q1 | $8.36M | Buy |
54,978
+34,740
| +172% | +$5.29M | 1.74% | 13 |
|
|
2013
Q4 | $2.69M | Buy |
20,238
+75
| +0.4% | +$9.97K | 0.58% | 65 |
|
|
2013
Q3 | $2.34M | Buy |
20,163
+1,081
| +6% | +$126K | 0.61% | 60 |
|
|
2013
Q2 | $1.76M | Buy |
+19,082
| New | +$1.76M | 0.55% | 61 |
|